GB1381588A - Process for the preparation of porous tablets - Google Patents

Process for the preparation of porous tablets

Info

Publication number
GB1381588A
GB1381588A GB4318773A GB4318773A GB1381588A GB 1381588 A GB1381588 A GB 1381588A GB 4318773 A GB4318773 A GB 4318773A GB 4318773 A GB4318773 A GB 4318773A GB 1381588 A GB1381588 A GB 1381588A
Authority
GB
United Kingdom
Prior art keywords
tablets
adjuvant
preparation
sept
porous tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4318773A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of GB1381588A publication Critical patent/GB1381588A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/01—Wetting, emulsifying, dispersing, or stabilizing agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
GB4318773A 1972-09-20 1973-09-14 Process for the preparation of porous tablets Expired GB1381588A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2246013A DE2246013A1 (de) 1972-09-20 1972-09-20 Verfahren zur herstellung von poroesen tabletten

Publications (1)

Publication Number Publication Date
GB1381588A true GB1381588A (en) 1975-01-22

Family

ID=5856791

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4318773A Expired GB1381588A (en) 1972-09-20 1973-09-14 Process for the preparation of porous tablets

Country Status (9)

Country Link
US (1) US3885026A (enExample)
JP (1) JPS4969819A (enExample)
AT (1) AT324568B (enExample)
CH (1) CH579394A5 (enExample)
DE (1) DE2246013A1 (enExample)
FR (1) FR2199973B1 (enExample)
GB (1) GB1381588A (enExample)
IT (1) IT998618B (enExample)
SE (1) SE395366B (enExample)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6455511B1 (en) 1994-09-22 2002-09-24 Quadrant Holdings Cambridge Limited Compositions for use in rehydration and nutrition during athletic exercise and methods of making same
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US7300919B2 (en) 1992-09-29 2007-11-27 Nektar Therapeutics Pulmonary delivery of active fragments of parathyroid hormone
US7306787B2 (en) 1997-09-29 2007-12-11 Nektar Therapeutics Engineered particles and methods of use
US7521069B2 (en) 1994-03-07 2009-04-21 Novartis Ag Methods and compositions for pulmonary delivery of insulin
US7628978B2 (en) 1997-09-29 2009-12-08 Novartis Pharma Ag Stabilized preparations for use in metered dose inhalers
US8246934B2 (en) 1997-09-29 2012-08-21 Novartis Ag Respiratory dispersion for metered dose inhalers comprising perforated microstructures
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US8709484B2 (en) 2000-05-10 2014-04-29 Novartis Ag Phospholipid-based powders for drug delivery
US8715623B2 (en) 2001-12-19 2014-05-06 Novartis Ag Pulmonary delivery of aminoglycoside
US8877162B2 (en) 2000-05-10 2014-11-04 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082837A (en) * 1975-03-10 1978-04-04 University Of Southern California Process for the selective catalytic oxidation of partially oxidized inorganic compounds
DE2556561C2 (de) * 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
US4568547A (en) * 1979-08-30 1986-02-04 Herschler R J Solid pharmaceutical compositions comprising MSM and their production
US4883182A (en) * 1985-05-31 1989-11-28 Hughes Raymond J Tamper evident capsule and insert device
GB8624628D0 (en) * 1986-10-14 1986-11-19 Scras Soluble/splitable tablets
ATE138563T1 (de) * 1991-12-20 1996-06-15 Pfizer Poröse geformte abgabevorrichtung und verfahren zur herstellung derselbe
ATE147261T1 (de) * 1992-01-13 1997-01-15 Pfizer Verfahren zur herstellung von tabletten mit hoher festigkeit
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE69739967D1 (de) * 1996-06-14 2010-09-30 Kyowa Hakko Kirin Co Ltd Eine im Mund schnell zerfallende Tablette
KR100481583B1 (ko) * 1996-06-14 2005-07-12 교와 핫꼬 고교 가부시끼가이샤 구강내에서빠르게붕괴하는정제
PT860170E (pt) 1996-08-13 2000-06-30 Kyowa Hakko Kogyo Kk Comprimidos a base de ureia marcada com isotopos
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.
RU2140262C1 (ru) * 1998-06-22 1999-10-27 ОАО "Ирбитский химико-фармацевтический завод" Способ получения таблеток бромкамфоры рацемической
HK1041441A1 (zh) 1998-11-10 2002-07-12 Teva Pharmaceutical Industries, Ltd. 包含l-多巴乙酯的可分散组合物
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
KR20010107754A (ko) * 2000-05-26 2001-12-07 민경윤 경구투여용 속용정의 제조 방법
US20030185886A1 (en) * 2000-05-26 2003-10-02 Hanmi Pharm. Co., Ltd. Process for the preparation of rapidly disintegrating tablet
GB0028709D0 (en) * 2000-11-24 2001-01-10 S P A Process
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
KR20030074810A (ko) * 2001-02-08 2003-09-19 파마시아 코포레이션 성 기능장애의 치료를 위한 신속-발현 약
EP1369109A1 (en) * 2001-03-06 2003-12-10 Kyowa Hakko Kogyo Co., Ltd. Preparations quickly disintegrating in oral cavity
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
KR20040098023A (ko) * 2002-03-26 2004-11-18 테바 파마슈티컬 인더스트리즈 리미티드 약물 미세입자
JP2006507266A (ja) * 2002-10-04 2006-03-02 ファルマシア・コーポレーション 性的機能不全を処置するための組成物および方法
AU2003284942A1 (en) * 2002-10-30 2004-06-07 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
AU2004238321B2 (en) * 2003-05-07 2009-08-27 Samyang Biopharmaceuticals Corporation Highly plastic granules for making fast melting tablets
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US8802145B2 (en) * 2004-10-28 2014-08-12 Pantec Ag Highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a powder and a freezedrying step
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
US20090068262A1 (en) * 2007-04-04 2009-03-12 Ilan Zalit Rapid dissolution of combination products
WO2009002084A2 (en) * 2007-06-27 2008-12-31 Hanmi Pharm. Co., Ltd. Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
CA2704209C (en) * 2007-10-31 2017-02-28 Mcneil-Ppc, Inc. Orally disintegrative dosage form
JP5594484B2 (ja) * 2009-07-06 2014-09-24 杏林製薬株式会社 中空構造を有する錠剤
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
US8343533B2 (en) * 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
CN102958515A (zh) 2009-12-02 2013-03-06 阿普塔利斯制药有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
AR079862A1 (es) * 2010-01-08 2012-02-22 Eurand Inc Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
EP3091966B1 (en) 2014-01-10 2019-07-31 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CN107595789B (zh) 2016-04-21 2021-01-15 阿斯利康(瑞典)有限公司 口腔崩解片
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
DE102023002336A1 (de) 2023-06-09 2024-12-12 euvorio GmbH Kohlenhydrathaltige Zusammensetzungen in Drageeform

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1742515A (en) * 1924-10-08 1930-01-07 Ambrose J Mandell Method of making porous objects
US2887437A (en) * 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
US3175521A (en) * 1961-02-23 1965-03-30 Schering Corp Apparatus for punching miniature tablets
US3371984A (en) * 1963-09-06 1968-03-05 Colgate Palmolive Co Air freshener
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3450494A (en) * 1967-07-18 1969-06-17 Conrad J Gaiser Amorphous sodium silicate having inherent binding properties and method of producing same
US3639286A (en) * 1968-05-28 1972-02-01 Mario Ballestra Synthetic detergent in bar or cake form and the method to manufacture same
GB1303102A (enExample) * 1969-01-16 1973-01-17
US3719599A (en) * 1969-11-25 1973-03-06 Lepetit Spa Solid lubricant composition and method of preparation
LU60170A1 (enExample) * 1970-01-09 1971-11-18
US3653914A (en) * 1970-03-20 1972-04-04 Alberto Culver Co Production of tablets
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
US3739048A (en) * 1971-05-26 1973-06-12 Sumitomo Electric Industries Method of granulating powder
US3789119A (en) * 1971-06-01 1974-01-29 Parke Davis & Co Stabilized molded sublingual nitroglycerin tablets

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300919B2 (en) 1992-09-29 2007-11-27 Nektar Therapeutics Pulmonary delivery of active fragments of parathyroid hormone
US7521069B2 (en) 1994-03-07 2009-04-21 Novartis Ag Methods and compositions for pulmonary delivery of insulin
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6596702B2 (en) 1994-09-22 2003-07-22 Elan Drug Delivery Limited Compositions for use in rehydration and nutrition during athletic exercise and methods of making same
US6455511B1 (en) 1994-09-22 2002-09-24 Quadrant Holdings Cambridge Limited Compositions for use in rehydration and nutrition during athletic exercise and methods of making same
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6331310B1 (en) 1994-12-02 2001-12-18 Quadrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US7744925B2 (en) 1994-12-02 2010-06-29 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US7785631B2 (en) 1994-12-02 2010-08-31 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US7056495B2 (en) 1994-12-02 2006-06-06 Quadrant Drug Delivery Ltd. Solid dose delivery vehicle and methods of making same
US6811792B2 (en) 1994-12-02 2004-11-02 Quadrant Drug Delivery Ltd. Solid dose delivery vehicle and methods of making same
US6893657B2 (en) 1994-12-02 2005-05-17 Quadrant Drug Delivery Ltd. Solid dose delivery vehicle and methods of making same
US6565871B2 (en) 1994-12-02 2003-05-20 Elan Drug Delivery Ltd. Solid dose delivery vehicle and methods of making same
US7780991B2 (en) 1994-12-02 2010-08-24 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US8168223B1 (en) 1997-09-29 2012-05-01 Novartis Pharma Ag Engineered particles and methods of use
US7628978B2 (en) 1997-09-29 2009-12-08 Novartis Pharma Ag Stabilized preparations for use in metered dose inhalers
US8246934B2 (en) 1997-09-29 2012-08-21 Novartis Ag Respiratory dispersion for metered dose inhalers comprising perforated microstructures
US7306787B2 (en) 1997-09-29 2007-12-11 Nektar Therapeutics Engineered particles and methods of use
US9554993B2 (en) 1997-09-29 2017-01-31 Novartis Ag Pulmonary delivery particles comprising an active agent
US8877162B2 (en) 2000-05-10 2014-11-04 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US8709484B2 (en) 2000-05-10 2014-04-29 Novartis Ag Phospholipid-based powders for drug delivery
US8715623B2 (en) 2001-12-19 2014-05-06 Novartis Ag Pulmonary delivery of aminoglycoside
US9421166B2 (en) 2001-12-19 2016-08-23 Novartis Ag Pulmonary delivery of aminoglycoside

Also Published As

Publication number Publication date
AT324568B (de) 1975-09-10
US3885026A (en) 1975-05-20
IT998618B (it) 1976-02-20
JPS4969819A (enExample) 1974-07-05
FR2199973A1 (enExample) 1974-04-19
SE395366B (sv) 1977-08-15
FR2199973B1 (enExample) 1979-01-05
DE2246013A1 (de) 1974-03-28
CH579394A5 (enExample) 1976-09-15

Similar Documents

Publication Publication Date Title
GB1381588A (en) Process for the preparation of porous tablets
CA971969A (en) Process for preparing hydantoin derivatives and herbicidal composition containing the same
CA991062A (en) Process for preparing aluminum alloys and article
CA1027109A (en) PROCESS FOR THE PREPARATION OF 17.alpha.-ESTERS OF 17.alpha., 21-DIHYDROXY-20-OXO STEROIDS
CA950218A (en) Process and system for increasing load-bearing capacity of soil
CA1007780A (en) Process for the preparation of polyurethane urea solutions
IE38031B1 (en) Phenylalkanoic acids
CA953909A (en) Process and apparatus for continuous treatment of dusty, powdery and granular materials
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
CA936533A (en) 5-aryl-2,3-dihydro-2,2(or 3,3) dimethyl-5h-imidazo(2,1-a) isoindol-5-ols and 2(4,4(5,5) dimethyl-2-imidazolin-2-yl) bensophenone acid addition salts and processes for their preparation
CA981665A (en) 9-desoxy-prosta-5,9(10),13-trienoic acid derivatives and process for their preparation
CA996804A (en) Amplification of low-density polyyne images
CA1004667A (en) 3-KETO-7(.alpha.,.beta.)LOWERALKYL-.DELTA.5-STEROIDS AND PROCESS FOR PREPARING SAME
CA931161A (en) PROCESS FOR PREPARING FREE-FLOWING .alpha.-OLEFIN SULFONATE POWDERS WHILE HYDROLYZING SULTONES
CA1020542A (en) PROCESS FOR THE MANUFACTURE OF .beta.-(3-OXO-7.alpha.-ACETYLTHIO-17.beta.-HYDROXY-4-ANDROSTEN-17.alpha.-YL)-PROPIONIC ACID .gamma.-LACTONE
CA1002686A (en) Process for preparing granular or powdered polyamide
GB1393226A (en) Therapeutic compositions and a process for the manufacture thereof
IL43562A (en) Pharmaceutical formulations containing allopurinol as inhibitor of xanthine oxidase
CA991880A (en) Structural unit consisting of beams and connecting elements for transporting and anchoring structural slabs
CA1002829A (en) Process of providing active surfaces
CA974908A (en) Process for preparing nicotinamide adenine dinucleotide phosphate
CA1000704A (en) 1,2,3-triazole derivatives and process for preparing them
CA1009236A (en) .beta.-AMINO-ACRYLIC ACID DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
GB1383292A (en) Process for preparing 1,3,4-thiadiazole-2-thiol compounds
AU450860B2 (en) Process for preparation of granular active carbon

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years

Effective date: 19930913